HCR Wealth Advisors’s Editas Medicine EDIT Stock Holding History

HCR Wealth Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,000	Closed	-$34.9K	–	248
2025 Q4	$34.9K	Hold	17,000	–	–	﹤0.01%	254
2025 Q3	$66.1K	Hold	17,000	–	–	0.01%	242
2025 Q2	$37.4K	Hold	17,000	–	–	﹤0.01%	235
2025 Q1	$19.7K	Hold	17,000	–	–	﹤0.01%	230
2024 Q4	$21.6K	Hold	17,000	–	–	﹤0.01%	228
2024 Q3	$58K	Hold	17,000	–	–	0.01%	227
2024 Q2	$79.4K	Hold	17,000	–	–	0.01%	218
2024 Q1	$126K	Sell	17,000 -5,000	-23%	-$41.5K	0.02%	218
2023 Q4	$223K	Hold	22,000	–	–	0.04%	185
2023 Q3	$172K	Hold	22,000	–	–	0.04%	165
2023 Q2	$181K	Hold	22,000	–	–	0.03%	168
2023 Q1	$160K	Hold	22,000	–	–	0.03%	167
2022 Q4	$195K	Hold	22,000	–	–	0.04%	166
2022 Q3	$269K	Hold	22,000	–	–	0.06%	141
2022 Q2	$260K	Buy	22,000 +1,000	+5%	+$13.4K	0.05%	147
2022 Q1	$399K	Buy	21,000 +1,250	+6%	+$23.2K	0.07%	139
2021 Q4	$524K	Hold	19,750	–	–	0.08%	134
2021 Q3	$811K	Sell	19,750 -1,300	-6%	-$71.2K	0.14%	109
2021 Q2	$1.19M	Buy	21,050 +1,300	+7%	+$48K	0.21%	92
2021 Q1	$830K	Hold	19,750	–	–	0.16%	100
2020 Q4	$1.39M	Hold	19,750	–	–	0.29%	70
2020 Q3	$554K	Hold	19,750	–	–	0.13%	98
2020 Q2	$609K	Hold	19,750	–	–	0.14%	87
2020 Q1	$392K	Buy	+19,750	New	+$498K	0.11%	100

Other funds holding EDIT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HCR Wealth Advisors's EDIT Position: Q1 2026 in Review

HCR Wealth Advisors sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 17,000 shares — an estimated $34.9K sold.

HCR Wealth Advisors first reported a position in EDIT in Q1 2020 and held it in 24 quarters. The position peaked at $1.39M in Q4 2020. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

HCR Wealth Advisors reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
HCR Wealth Advisors sold 17,000 Editas Medicine shares in Q1 2026, an estimated $34.9K.
HCR Wealth Advisors first reported a position in Editas Medicine in Q1 2020 and held it in 24 quarters.
HCR Wealth Advisors's Editas Medicine position peaked at $1.39M in Q4 2020.
208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on HCR Wealth Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.